Sort
51,593 grants matching “hepatitis”
Accurate Point of Care Liver Disease Diagnostics, Phase II
$947,354Pablo J Prado · Livivos Inc. · R44 · FY2025 · DK
Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST)
$945,958Juliet Iwelunmor · Washington University · UG1 · FY2025 · HD
Saline Enhanced Radiofrequency Ablation for Liver Tumors
$945,936Michael G Curley · Thermedical, Inc. · R44 · FY2008 · CA
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
$945,785Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2021 · DK
Modulation of the immune response to B cell lineage-based immunization by other immune interventions administered in infancy
$944,979Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
$944,831Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2014 · DA
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
$944,500Hilde Cheroutre · La Jolla Institute For Immunology · DP1 · FY2009 · OD
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
$944,500Hilde Cheroutre · La Jolla Institute For Immunology · DP1 · FY2010 · OD
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$944,359Michael David Hughes · Harvard School Of Public Health · UM1 · FY2022 · AI
EPIDEMIOLOGY OF HUMAN RETROVIRUSES IN BLOOD DONORS
$944,284American National Red Cross Los Angeles · N01 · FY2000 · HB
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
$943,466Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Structural studies of native-like SOSIP trimers
$943,450Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · AI
Therapeutic Strategies for the Management of HCV/HIV co- infection
$943,367Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
The National Drug Abuse Treatment Clinical Trials Network
$943,255Walter Nmn Ling · University Of California Los Angeles · U10 · FY2010 · DA
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$943,211John A. Howard · Applied Biotechnology Institute · R44 · FY2012 · AI
Integration of HIV/AIDS, Viral Hepatitis, STD, and TB Programs
$942,892James W Gillan · Guam Department/ Health/Social Services · U52 · FY2013 · PS
Data-Driven Approaches for Opioid Use Disorder Treatment, Recovery, and Overdose Prevention in Rural Communities via Mobile Health Clinics and Peer Support Services
$942,574Lior Rennert · Clemson University · R61 · FY2023 · DA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$942,313Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$942,313Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Automated Molecular Diagnostics for Rapid Detection of Dengue Viremia Using Whole
$942,026Shuqi Chen · Iquum, Inc. · R44 · FY2011 · AI
Molecular Mechanisms of TGF-beta Signaling Pathway
$941,483Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Optimizing eCD4-Ig for eradication and a functional cure
$941,035Michael R. Farzan · Scripps Florida · R01 · FY2020 · AI
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$940,899Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Optimizing eCD4-Ig for eradication and a functional cure
$940,275Michael R. Farzan · Scripps Florida · R01 · FY2019 · AI
CCR FACS Core Laboratory
$939,713Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA